Switch to:

Trevi Therapeutics EV-to-EBITDA

: -0.59 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Trevi Therapeutics's enterprise value is $17.58 Mil. Trevi Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $-29.79 Mil. Therefore, Trevi Therapeutics's EV-to-EBITDA for today is -0.59.

NAS:TRVI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.73   Med: 0   Max: 1.11
Current: -0.59

-7.73
1.11

During the past 3 years, the highest EV-to-EBITDA of Trevi Therapeutics was 1.11. The lowest was -7.73. And the median was 0.00.

NAS:TRVI's EV-to-EBITDA is ranked lower than
99.99% of the 285 Companies
in the Biotechnology industry.

( Industry Median: 31.31 vs. NAS:TRVI: -0.59 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-11-27), Trevi Therapeutics's stock price is $3.09. Trevi Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $-1.67. Therefore, Trevi Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Trevi Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Trevi Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-EBITDA 0.00 0.00 -0.38

Trevi Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -0.38 -0.21 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Trevi Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Trevi Therapeutics's EV-to-EBITDA falls into.



Trevi Therapeutics EV-to-EBITDA Calculation

Trevi Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=17.578/-29.791
=-0.59

Trevi Therapeutics's current Enterprise Value is $17.58 Mil.
Trevi Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was -6.532 (Dec. 2019 ) + -8.629 (Mar. 2020 ) + -7.402 (Jun. 2020 ) + -7.228 (Sep. 2020 ) = $-29.79 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Trevi Therapeutics  (NAS:TRVI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Trevi Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.09/-1.666535
=

Trevi Therapeutics's share price for today is $3.09.
Trevi Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was -0.366535 (Dec. 2019 ) + -0.48 (Mar. 2020 ) + -0.41 (Jun. 2020 ) + -0.41 (Sep. 2020 ) = $-1.67.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Trevi Therapeutics EV-to-EBITDA Related Terms


Trevi Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)